Phoenix Asia Holdings Ltd
corporate_fare Company Profile
Phoenix Asia Holdings Ltd (NASDAQ:PHOE) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 6 items for PHOE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 10/10, with 6 rated 8 or above. Recent SEC coverage for PHOE spans 6-K, 20-F.
Recent high-impact activity:
- Phoenix Asia Calls EGM to Create Dual-Class Structure and Issue 7.5M Super-Voting Shares to Controlling Holder
- Phoenix Asia Terminates $1B-Scale ACEA Pharma Acquisition After Outside Date
- Phoenix Asia Swings to Loss, Gross Margin Collapses to 4.6%
- Phoenix Asia Holdings to Acquire ACEA Pharma in Transformational $1 Billion Stock Deal, Issuing 100 Million New Shares
- Phoenix Asia to Issue 100M Shares for Pharma Acquisition, Signaling Massive Dilution and Strategic Pivot
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,085 shares in PHOE as of the October 30, 2026 settlement, a 2.4% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 46.6% of PHOE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
PHOE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.